An important discovery relating to Alzheimer's disease and dementia has been made by researchers at an institution in the south-west of England.
According to scientists at Bristol University, the enzyme known as endothelin converting enzyme-2 (ECE-2) may be responsible for a drop in blood flow in the brain, resulting in a worsening condition for the person with Alzheimer's.
The results were published in the American Journal of Pathology this month.
Mark Poarch, the chief executive of Bristol-based charity BRACE, which funded a lot of the study, said of the results: "This is real progress and opens up new areas for research. It is also good news for the thousands of local people who have raised money to try to beat Alzheimer's."
BRACE - or Bristol Research in Alzheimer's and Care of the Elderly - continues to raise funds for dementia and Alzheimer's disease alone, stumping up £10 million since 1987.
Please click here for advice to help you find the right type of care.